Revolution Medicines News

S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 8 17:17 ET

8-K: Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

May 8 16:10 ET

DEFA14A: Others

Apr 25 16:41 ET

DEF 14A: Definitive information statements

Apr 25 16:38 ET

Revolution Medicines | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 4 17:27 ET

Revolution Medicines | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 26 17:07 ET

Revolution Medicines | 8-K: Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Feb 26 16:09 ET

Revolution Medicines | 8-K: Current report

Jan 9 00:00 ET

Revolution Medicines | 8-K/A: Current report (Amendment)

Dec 26, 2023 00:00 ET

Revolution Medicines | 8-K: Current report

Nov 9, 2023 09:20 ET

Revolution Medicines | 8-K: Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress

Nov 6, 2023 16:05 ET

Revolution Medicines | DEFA14A: Others

Nov 1, 2023 07:15 ET

Revolution Medicines | 8-K: Current report

Nov 1, 2023 07:08 ET

Revolution Medicines | 8-K: Current report

Oct 23, 2023 06:11 ET

Revolution Medicines | 8-K: Current report

Oct 13, 2023 11:54 ET

Revolution Medicines | DEFM14A: Definitive proxy statement relating to merger or acquisition

Sep 29, 2023 16:19 ET

Revolution Medicines | 8-K: Current report

Sep 5, 2023 16:02 ET

Revolution Medicines | 8-K: Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress

Aug 8, 2023 16:04 ET

Revolution Medicines | 8-K: Current report

Aug 1, 2023 07:10 ET

Revolution Medicines | 8-K: Current report

Jun 9, 2023 16:07 ET